Julio Takada

Dr. Julio Takada

Sociedade Brasileira de Cardiologia
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Closed access
AMAntonio Mansur
Antonio Mansur
MRMarcos Abs Rocha
Marcos Abs Rocha
VLVilma Leyton
Vilma Leyton
JTJulio Takada
Julio Takada
SASolange Desirée Avakian
Solange Desirée Avakian
WRWaldo J C Rohlfs
Waldo J C Rohlfs

1 January 2012 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
AMAntonio Mansur
Antonio Mansur
TSTereza Cristina B. F. Silva
Tereza Cristina B. F. Silva
JTJulio Takada
Julio Takada
SASolange Desirée Avakian
Solange Desirée Avakian
CSCelia Maria Cassaro Strunz
Celia Maria Cassaro Strunz
JRJosé Antonio F. Ramires
José Antonio F. Ramires
Background. The link between endogenous estrogen, coronary artery disease (CAD), and death in postmenopausal women is uncertain. We analyzed the association between death and blood levels of estrone in postmenopausal women with known coronary artery disease (CAD) or with a high-risk factor score for CAD.Methods. 251 postmenopausal women age 50–90 years not on estrogen therapy. Fasting blood for estrone and heart disease risk factors were collected at baseline. Women were grouped according to their estrone levels (<15 and ≥15 pg/mL). Fatal events were recorded after5.8±1.4years of followup.Results. The Kaplan-Meier survival curve showed a significant trend (P=0.039) of greater all-cause mortality in women with low estrone levels (<15 pg/mL). Cox multivariate regression analysis model adjusted for body mass index, diabetes, dyslipidemia, family history, and estrone showed estrone (OR=0.45;P=0.038) as the only independent variable for all-cause mortality. Multivariate regression model adjusted for age, body mass index, hypertension, diabetes, dyslipidemia, family history, and estrone showed that only age (OR=1.06;P=0.017) was an independent predictor of all-cause mortality.Conclusions. Postmenopausal women with known CAD or with a high-risk factor score for CAD and low estrone levels (<15 pg/mL) had increased all-cause mortality.

1 September 2005 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
JTJulio Takada
Julio Takada
MSM.C. Solimene
M.C. Solimene
PLP.L. da Luz
P.L. da Luz
CGC.J. Grupi
C.J. Grupi
DGD.M.A. Giorgi
D.M.A. Giorgi
JRJ.A.F. Ramires
J.A.F. Ramires

1 January 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
JTJulio Takada
Julio Takada
RRRogério B Ramos
Rogério B Ramos
LRLarissa C Roza
Larissa C Roza
SASolange D Avakian
Solange D Avakian
JRJosé Antonio F Ramires
José Antonio F Ramires
AMAntonio Mansur
Antonio Mansur
Admission hyperglycaemia is associated with mortality in patients with acute coronary syndrome (ACS), but controversy exists whether hyperglycaemia uniformly affects both genders. We evaluated coronary risk factors, gender, hyperglycaemia and their effect on hospital mortality.

1 March 2022 in Physiotherapy
Verified
Journal Article
Closed access
GAG.N. Andrade
G.N. Andrade
TRT. Rodrigues
T. Rodrigues
JTJulio Takada
Julio Takada
LBL.M. Braga
L.M. Braga
IUI.I.K. Umeda
I.I.K. Umeda
NNNaomi Kondo Nakagawa
Naomi Kondo Nakagawa

1 August 2002 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
DRDemetrio Ortega Rumi
Demetrio Ortega Rumi
MSMaria Cecília Solimene
Maria Cecília Solimene
JTJulio Takada
Julio Takada
CGCésar José Grupi
César José Grupi
DGDante Marcelo Giorgi
Dante Marcelo Giorgi
JRJosé Antonio Franchini Ramires
José Antonio Franchini Ramires
To study cardiovascular alterations in young patients with no apparent organic disease who underwent electroconvulsive therapy. The study comprised 47 healthy patients (22 males and 25 females) with a mean age of 30.3 years, who underwent electroconvulsive therapy. Ambulatory blood pressure monitoring and continuous electrocardiographic monitoring (Holter monitor) were performed during 24 hours. Blood pressure and heart rate were assessed 4 hours prior to electric shock administration, during electric shock administration, and 3 hours after electric shock administration. Arrhythmias and alterations in the ST segment in 24 hours were recorded. On electroconvulsive therapy, a significant increase in blood pressure and heart rate was observed and the measurements returned to basal values after 25 minutes. Three females had tracings with depression of the ST segment suggesting myocardial ischemia prior to and after electroconvulsive therapy. Coronary angiography was normal. No severe cardiac arrhythmias were diagnosed. 1) Electroconvulsive therapy is a safe therapeutic modality in psychiatry; 2) it causes a significant increase in blood pressure and heart rate; 3) it may be associated with myocardial ischemia in the absence of coronary obstructive disease; 4) electroconvulsive therapy was not associated with the occurrence of severe cardiac arrhythmias.